MedTrace Logo

Long Term Outcomes of Venous Thromboembolism

NCT02268630 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 460

Last updated 2017-02-16

No results posted yet for this study

Summary

This prospective observational follow-up study is designed to assess the long-term outcomes after Venous thromboembolism (VTE) and to assess the effect of the new oral anticoagulant (NOAC) rivaroxaban on the prevalence of post-thrombotic syndrome (PTS).

The study will not be testing any formal hypothesis.

Conditions

  • Post Thrombotic Syndrome
  • Chronic Thromboembolic Pulmonary Hypertension
  • Venous Thrombosis

Sponsors & Collaborators

  • Ostfold Hospital Trust

    lead OTHER

Principal Investigators

  • Kristin K Utne, MD · Ostfold Hospital Trust

  • Waleed Ghanima, PhD · Ostfold Hospital Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02268630 on ClinicalTrials.gov